墨尔本评估第二版在脑瘫儿童中的心理测量与临床测量特性
本研究在5至12岁脑瘫儿童中检验墨尔本评估第二版(MA2)的信度、效度、反应度及最小可检测变化(MDC)与最小临床重要差异(MCID)。结果显示MA2信度高、效度获支持、反应度良好,并报告了4个子量表的MDC与建议MCID值,提示其适用于研究与临床应用。
要点
- MA2包含关节活动度、流畅性、准确性和灵巧性4个子量表。
- 重测信度高(ICC .92-.98),与BBT、BOT-2、PMAL-R的相关支持效度。
- 配对t检验P<.001且标准化反应均值为1.70-2.00,确认反应度。
核心结论
- MA2具有可靠的心理测量与临床测量特性,适合用于研究与临床应用。
研究设计与样本
- 心理测量与临床测量研究,社区设置。
- 35名脑瘫儿童接受8周强化神经康复干预,用于估计效度、反应度与最小临床重要差异(MCID)。
主要发现
- MA2包含关节活动度、流畅性、准确性和灵巧性4个子量表。
- MA2的重测信度高,组内相关系数(ICC)为.92-.98。
- MA2与BBT、BOT-2及PMAL-R之间存在显著关系,支持其效度。
- 配对t检验结果显著(P<.001)且标准化反应均值为1.70-2.00,确认MA2的反应度。
关键数值与推荐
- MA2四个子量表的MDC值分别为2.85、1.63、1.97和1.84。
- MA2四个子量表建议的MCID值分别为2.35、3.20、2.09和2.22。
- 上述MDC与MCID值表示可解释为统计学显著且临床重要改善的最低分数。
临床怎么用
- 在脑瘫儿童上肢功能评估中,可使用MA2的4个子量表进行测量。
- 解读MA2子量表变化时,可参考对应的MDC与MCID值判断改善是否具有统计学与临床意义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the psychometric and clinimetric properties of the Melbourne Assessment 2 (MA2), an outcome measurement that is increasingly used in clinical studies. DESIGN: Psychometric and clinimetric study. SETTING: Community. PARTICIPANTS: Seventeen children with cerebral palsy (CP) from 5 to 12 years were recruited for the estimation of the test-retest reliability and minimal detectable change (MDC). Thirty-five children with CP were recruited to receive an 8-week intensive neurorehabilitation intervention to estimate the validity, responsiveness, and minimal clinically important difference (MCID). INTERVENTIONS: Thirty-five children with CP received upper limb neurorehabilitation programs for 8 weeks. MAIN OUTCOME MEASURES: The MA2 and the criterion measures, including the Bruininks-Oseretsky Test of Motor Proficiency, 2nd edition (BOT-2), the Box and Blocks Test (BBT), and the Pediatric Motor Activity Log-Revised (PMAL-R), were evaluated at pretreatment and posttreatment. RESULTS: The MA2 has 4 subscales: range of motion, fluency, accuracy, and dexterity. The test-retest reliability of the MA2 is high (intraclass correlation coefficient, .92-.98). The significant relationships between the MA2 and BBT, BOT-2, and PMAL-R support its validity. The significance of paired t test results (P<.001) and large magnitudes of the standardized response mean (1.70-2.00) confirm the responsiveness of the MA2. The MDC values of the 4 subscales of the MA2 are 2.85, 1.63, 1.97, and 1.84, respectively, and the suggested MCID values of these 4 subscales are 2.35, 3.20, 2.09, and 2.22, respectively, indicating the minimum scores of improvement to be interpreted as both statistically significant and clinically important. CONCLUSIONS: The study findings indicate that the MA2 has sound psychometric and clinimetric properties and is thus an adequate measurement for research and clinical applications.
引用
- Wang TN, Liang KJ, Liu YC, et al. Psychometric and Clinimetric Properties of the Melbourne Assessment 2 in Children With Cerebral Palsy. Arch Phys Med Rehabil. 2017. PMID: 28254639. doi:10.1016/j.apmr.2017.01.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。